Skip to main content
. 2017 Apr 1;8(28):45213–45223. doi: 10.18632/oncotarget.16779

Figure 7. Schema of the mechanisms implicated in miR-27a antioligonucleotides-sensitized apoptosis in TRAIL-treated colorectal CSCs.

Figure 7

MiR-27a antioligonucleotides promote TRAIL-dependent formation of Apaf-1/caspase-9 complex by increasing the expression of Apaf-1. As a result, caspase-9 is triggered, followed by activation of caspase-3 and occurrence of apoptosis finally.